articleTop 1% cited
Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion
Ophthalmology · 2010 · Vol. 117(6) · pp. 1102–1112.e1
Peter A. Campochiaro✉(Johns Hopkins University)Jeffrey S. Heier(Ophthalmic Consultants of Boston)Leonard Feiner(Retina Associates)Sarah GrayNamrata SarojAmy Chen RundleWendy Yee MurahashiRoman G. Rubio
Retinal Diseases and TreatmentsGlaucoma and retinal disordersRetinal and Optic ConditionsRanibizumabMedicineMacular edemaBranch retinal vein occlusionOphthalmologyVisual acuityRandomized controlled trialConfidence intervalCentral retinal vein occlusionSurgery
Citations
801
FWCI
47.65
field-weighted impact
References
37
Percentile
100%
vs. same field & year
Citations per year
Cited by
Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study
Ophthalmology · 2011 · 700 citations
References
A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion
Archives of Ophthalmology · 2009 · 675 citations
The Biology of Vascular Endothelial Growth Factor
Endocrine Reviews · 1997 · 4,356 citations
Argon Laser Photocoagulation for Macular Edema in Branch Vein Occlusion
American Journal of Ophthalmology · 1984 · 769 citations
Photocoagulation for Diabetic Macular Edema
Archives of Ophthalmology · 1985 · 2,519 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.